Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Renal indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Alport syndrome and thin-basement-membrane disease

Renal · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Macroscopic haematuria alone is often self-limiting in collagen IV disease, but clots, urinary obstruction, severe loin pain, oedema, marked hypertension or an acute creatinine rise require urgent assessment for another or superimposed process. Pregnancy with hypertension, proteinuria or falling renal function needs prompt obstetric–renal review.

Overview

Recognise inherited type IV collagen disease, replace misleading benign labels with genetic risk assessment, and protect kidneys and families longitudinally.

Type IV collagen networks give the glomerular basement membrane strength and specialised filtration properties. Early biopsy may show diffuse thinning; with progressive Alport disease, electron microscopy can reveal irregular thickening, splitting and lamellation. This evolution explains why a thin membrane on one biopsy cannot by itself settle prognosis or inheritance.

Clinical severity depends on gene, inheritance and variant as well as sex in X-linked disease. Males with pathogenic COL4A5 variants often have higher kidney-failure risk, but heterozygous females can develop proteinuria, hypertension and kidney impairment. Biallelic COL4A3 or COL4A4 variants cause autosomal-recessive disease; heterozygous variants span isolated haematuria to progressive CKD.

The diagnostic unit is the family. A three-generation pedigree, audiology, eye examination where indicated and genomic testing can identify relatives needing surveillance and those who should not donate a kidney. Management centres on early antiproteinuric therapy, cardiovascular prevention and preparation for kidney replacement, with specialist advice for pregnancy and uncertain variants.

Key points

  • Alport syndrome results from pathogenic COL4A3, COL4A4 or COL4A5 variants affecting the glomerular basement membrane, cochlea and eye.

Aetiology

01

X-linked collagen IV disease

Pathogenic COL4A5 variants cause the common X-linked form; men often have earlier severe renal disease, while heterozygous women remain affected and require lifelong assessment.

02

Autosomal recessive disease

Biallelic COL4A3 or COL4A4 variants disrupt the same basement-membrane network and can produce severe renal, auditory and ocular disease in any sex.

03

Heterozygous COL4A3 or COL4A4 disease

Single pathogenic variants may produce thin-basement-membrane appearances, persistent haematuria and variable later proteinuric kidney disease rather than a uniformly benign carrier state.

Pathophysiology

  1. 1
    Abnormal collagen network

    Defective alpha-chain assembly weakens specialised type IV collagen networks in glomerular, cochlear and ocular basement membranes.

  2. 2
    Progressive glomerular barrier injury

    The glomerular basement membrane becomes abnormally thin, thickened or split, permitting persistent erythrocyte leakage and later albumin loss.

  3. 3
    Nephron scarring

    Repeated mechanical and cellular stress drives podocyte loss, segmental sclerosis and interstitial fibrosis, leading to hypertension and declining filtration.

  4. 4
    Extrarenal tissue dysfunction

    Comparable collagen defects in the cochlea and eye cause sensorineural hearing impairment and characteristic lens or retinal abnormalities.

Clinical features and red flags

Persistent glomerular haematuria

Repeated non-urological microscopic haematuria, especially from childhood or after infections, is the most common early renal clue.

Progression marker

New albuminuria, hypertension or falling eGFR indicates more than isolated thin membranes and increases urgency of renal protection.

Hearing involvement

Bilateral high-frequency sensorineural hearing loss supports Alport syndrome and may emerge during later childhood or adult life.

Ocular phenotype

Anterior lenticonus or characteristic retinal flecks are diagnostically helpful, while acute visual symptoms still require ordinary urgent ophthalmic assessment.

Pregnancy deteriorationRed flag

Rising blood pressure, proteinuria or creatinine during pregnancy requires urgent differentiation of renal disease progression from pre-eclampsia.

Investigations

  1. 01
    Urinalysis, microscopy and urine ACRFirst step
    Why
    Confirm glomerular haematuria and quantify the prognostically important protein component.
    Interpretation and limitations
    Persistent dysmorphic haematuria supports glomerular origin; rising albuminuria changes risk even if eGFR remains preserved.
  2. 02
    Creatinine, eGFR and blood pressure trend
    Why
    Detect progression and define cardiovascular and pregnancy risk.
    Interpretation and limitations
    Serial slope is more informative than one creatinine; apparent normality in a young adult does not remove substantial lifetime genetic risk.
  3. 03
    COL4A3, COL4A4 and COL4A5 genomic testing
    Why
    Establish molecular diagnosis and inheritance for the individual and family.
    Interpretation and limitations
    A pathogenic or likely pathogenic variant can guide cascade testing; uncertain variants require phenotype, segregation and genetics review rather than deterministic counselling.
  4. 04
    Audiology and targeted ophthalmology
    Why
    Identify extrarenal collagen IV manifestations and strengthen phenotyping.
    Interpretation and limitations
    Normal early testing does not exclude Alport syndrome; repeat is driven by genotype, age, symptoms and specialist plan.
  5. 05

Differential diagnosis

01

IgA nephropathy

Visible haematuria around respiratory infections can occur in both conditions; biopsy immune staining and collagen genetic findings distinguish mesangial IgA deposition from inherited basement-membrane disease.

02

Post-infectious glomerulonephritis

A latent nephritic illness with oedema, hypertension and low complement favours infection-related disease rather than lifelong familial microscopic haematuria.

03

Other inherited nephropathies

Atypical extrarenal findings or an inheritance pattern inconsistent with collagen IV disease should prompt broader genomic and specialist assessment.

04

Urological bleeding

Clots, dysuria, colic or malignancy risk suggest a urinary-tract source, whereas dysmorphic erythrocytes, albuminuria and a family renal history support glomerular bleeding.

Management

01SuspectIdentify a collagen IV familyFirst stepPersistent haematuria occurs with family, auditory or ocular clues.+
  1. 1Exclude transient infection and obvious urological bleeding while confirming renal haematuria and quantitative albuminuria.
  2. 2Construct a pedigree covering kidney failure, haematuria, hearing loss, eye findings and potential inheritance through maternal and paternal lines.
  3. 3Refer to nephrology or renal genetics for genomic testing and counselling, using biopsy selectively when the molecular and clinical pictures remain unresolved.
02ProtectRespond to proteinuria and progressionAlbuminuria, hypertension or falling eGFR emerges.+
  1. 1Start or optimise a single ACE inhibitor or ARB through the renal plan, recording baseline blood pressure, creatinine and potassium.

Complications

01

Progressive kidney failure

Proteinuria, hypertension and accumulated glomerular scarring can lead to chronic kidney disease and eventual kidney replacement needs, with timing varying widely by genotype.

02

Sensorineural hearing loss

Cochlear basement-membrane dysfunction causes bilateral high-frequency hearing impairment that may emerge only later in childhood or adult life.

03

Ocular disease

Anterior lenticonus and characteristic retinal changes can impair vision or support the diagnosis, although sudden visual symptoms still require ordinary urgent assessment.

04

Pregnancy-associated deterioration

Pre-existing proteinuria and impaired filtration increase the risk of hypertension, worsening kidney function and diagnostic difficulty with superimposed pre-eclampsia.

Monitoring and follow-up

  • Measure blood pressure, ACR and eGFR at a frequency matched to genotype, age, proteinuria and previous slope.
  • Repeat hearing assessment when symptoms develop or at the interval recommended by the inherited-kidney team.
  • Review treatment, renal function and pregnancy intentions before conception because RAAS blockers are contraindicated in pregnancy.
  • Update the pedigree as relatives are diagnosed and revisit variant classification through genetics when new evidence emerges.
  • Reassess potential kidney donors independently with access to family molecular results and long-term risk counselling.

Special situations

Thin is not automatically benign

A thin basement membrane can be an early or heterozygous collagen IV phenotype with meaningful lifetime risk.

Women are clinically affected

X-linked heterozygosity can cause progressive kidney disease, making the term carrier potentially misleading in clinical care.

Genotype serves several decisions

One molecular result can refine diagnosis, inheritance, surveillance, reproductive advice and living-donor eligibility.

Normal hearing does not exclude disease

Auditory manifestations may be age-dependent and are not present in every collagen IV genotype.

Transplant disease usually does not recur

The graft contains normal donor collagen, although rare post-transplant anti-GBM disease is a recognised specialist complication.

Common pitfalls

  1. 01

    Reassuring a patient that thin-basement-membrane disease can never progress.

  2. 02

    Describing women with X-linked Alport syndrome as unaffected carriers.

  3. 03

    Offering a related donor nephrectomy without genotype-informed renal assessment.

  4. 04

    Treating a variant of uncertain significance as proof of disease or absence of risk.

  5. 05

    Ignoring proteinuria because haematuria has been stable for years.

  6. 06

    Continuing an ACE inhibitor into pregnancy without preconception review.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
RenalOriginal SBA

Reframing thin membranes

A 34-year-old with persistent microscopic haematuria was labelled with benign thin-basement-membrane disease. Her father reached kidney failure and she now has albuminuria. What is the best next step?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Renal topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKKA Alport clinician informationUK-focused diagnosis and management resource.
  • UKKA Alport Rare Disease GroupGenetic diagnosis, female risk, pregnancy and family priorities.
  • NICE CKD recommendationsAlbuminuria, RAAS blockade, referral and CKD monitoring framework.
  • NHS England Genomic Medicine ServiceNHS genomic laboratory route and regional service structure.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
  • X-linked COL4A5 disease is common, but autosomal recessive and dominant collagen IV disease create wide variability within and between families.
  • Persistent glomerular haematuria from childhood, family kidney failure, sensorineural deafness or characteristic ocular signs should prompt genetic evaluation.
  • Thin-basement-membrane disease is a histological description, not a guarantee of benign prognosis; many affected people have heterozygous COL4A3 or COL4A4 variants.
  • Proteinuria, hypertension and a declining eGFR indicate higher renal risk and should trigger nephrology-led kidney protection.
  • Genetic testing can establish inheritance, spare some people an invasive biopsy, enable cascade testing and inform reproductive and living-donor decisions.
  • Women with X-linked disease are affected individuals, not merely carriers, and need lifelong renal assessment and pregnancy counselling.
  • Potential related kidney donors require genotype-informed assessment because microscopic haematuria or apparently mild disease can conceal lifelong risk.
    • Kidney biopsy with electron microscopy
    Why
    Clarify diagnosis when genetics is unresolved or another renal lesion is suspected.
    Interpretation and limitations
    Diffuse thinning may overlap heterozygous disease, while lamellation and irregularity support Alport; chronic scarring contributes prognosis.
    2
    Address smoking, lipids, weight and avoidable nephrotoxins while tracking ACR and eGFR slope.
  • 3EscalationEscalate for kidney-failure risk assessment and replacement preparation early enough to discuss transplantation and family donor implications.
    • 03CascadeTranslate diagnosis across the familyA pathogenic collagen IV variant or strong clinical diagnosis is established.+
    1. 1Offer genetics-led testing to appropriate relatives with age-appropriate consent and explain variable expression rather than predicting identical outcomes.
    2. 2Arrange renal surveillance for affected relatives, including women with X-linked disease, and audiology or eye review according to phenotype.
    3. 3Require specialist assessment before pregnancy or related kidney donation; never reassure solely from a normal creatinine or mild haematuria.
    Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
    Reduces proteinuria and intraglomerular pressure, aiming to delay collagen IV kidney disease progression.

    ACE inhibitor or angiotensin-receptor blocker

    Use one locally preferred agent and titrate to albuminuria, blood pressure and tolerance under the renal plan; avoid combining the two classes.

    Monitor creatinine and potassium after initiation and titration. Follow pregnancy contraindications and provide preconception medicine review; reassess during dehydration, hypotension or significant acute illness.